Does CAPLACIZUMAB-YHDP Cause Cerebral infarction? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Cerebral infarction have been filed in association with CAPLACIZUMAB-YHDP. This represents 0.4% of all adverse event reports for CAPLACIZUMAB-YHDP.
5
Reports of Cerebral infarction with CAPLACIZUMAB-YHDP
0.4%
of all CAPLACIZUMAB-YHDP reports
1
Deaths
4
Hospitalizations
How Dangerous Is Cerebral infarction From CAPLACIZUMAB-YHDP?
Of the 5 reports, 1 (20.0%) resulted in death, 4 (80.0%) required hospitalization.
Is Cerebral infarction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAPLACIZUMAB-YHDP. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does CAPLACIZUMAB-YHDP Cause?
Product use in unapproved indication (465)
Adamts13 activity decreased (136)
Off label use (133)
Platelet count decreased (126)
Epistaxis (123)
Fatigue (110)
Contusion (86)
Injection site pain (74)
Headache (71)
Adamts13 activity abnormal (63)
What Other Drugs Cause Cerebral infarction?
RIVAROXABAN (1,367)
APIXABAN (937)
DABIGATRAN ETEXILATE (713)
ASPIRIN (535)
EDOXABAN (419)
CLOPIDOGREL BISULFATE (315)
PEMBROLIZUMAB (295)
BEVACIZUMAB (269)
METHOTREXATE (265)
NIVOLUMAB (262)
Which CAPLACIZUMAB-YHDP Alternatives Have Lower Cerebral infarction Risk?
CAPLACIZUMAB-YHDP vs CAPMATINIB
CAPLACIZUMAB-YHDP vs CAPREOMYCIN
CAPLACIZUMAB-YHDP vs CAPSAICIN
CAPLACIZUMAB-YHDP vs CAPTOPRIL
CAPLACIZUMAB-YHDP vs CARBAMAZEPINE